Description |
Ferrostatin-1 is a potent inhibitor of ferroptosis with an EC50 of 60 nM.
|
Target |
EC50: 60 nM (Ferroptosis)[1]
|
In Vitro |
Ferrostatin-1 is the most potent inhibitor of erastin-induced ferroptosis in HT-1080 cells (EC50=60 nM). Ferrostatin-1 does not inhibit ERK phosphorylation or arrest the proliferation of HT-1080 cells. Ferrostatin-1 does, however, prevent erastin-induced accumulation of cytosolic and lipid ROS[1]. Cells pretreated with 0.4 μM Ferrostatin-1 displays significantly reduce intracellular reactive oxygen species (ROS) and nitrogen species (RNS) below basal levels. Additionally, increased intracellular ROS levels are also significantly lowered below basal levels by a 0.4 µM Ferrostatin-1 pretreatment. Ferrostatin-1 treatment for 24 h does not change the expression level of i-NOS in SHSY-5Y cell when compare with vehicle (0.02 % DMSO) treated cells[2].
|
Cell Assay |
SH-S5Y cells are seeded in 24-well plates. After overnight incubation, the cells are exposed for 24 h to 1 µM of Ferrostatin-1, under standard growth conditions. Bright field photomicrographs are captured using an inverted microscope equipped with 10× objective in a live-cell modality[2].
|
Density | 1.1±0.1 g/cm3 |
Boiling Point | 437.3±35.0 °C at 760 mmHg |
Flash Point | 218.3±25.9 °C |
Exact Mass | 262.168121 |
PSA | 64.35000 |
LogP | 3.90 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Storage condition | 2-8°C |